Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
- PMID: 7548469
- DOI: 10.1016/0006-3223(94)00252-X
Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
Abstract
This study tests the hypothesis that nicotinic cholinergic receptors, including those sensitive to the antagonist alpha-bungarotoxin, are decreased in the hippocampus of schizophrenics. The hypothesis is derived from the finding that alpha-bungarotoxin causes a defect in the inhibitory gating of auditory-evoked potentials in laboratory animals that resembles a defect in auditory sensory gating observed in schizophrenics. Nicotine transiently normalizes this psychophysiological deficit in schizophrenic patients. Postmortem brain tissue was obtained from eight schizophrenic and eight age-matched nonschizophrenic subjects. Sections of the hippocampus were labeled with [125I alpha-bungarotoxin and imagined by autoradiography. Binding of the nicotinic agonist [3H]-cytisine was determined in tissue homogenates. alpha-Bungarotoxin labeled a population of putative interneurons in the hippocampus, primarily in the dentate gyrus and the CA3 region of Ammon's horn. This labeling was significantly decreased in the tissue from the schizophrenic patients, with seven or eight patients below the range of the nonschizophrenic subjects. There was also a significant decrease in the binding of cytisine. The results were not related to generalized hippocampal cell loss, drug exposure at time of death, or smoking history. This initial study suggests that schizophrenic patients have fewer nicotinic receptors in the hippocampus, a condition which may lead to failure of cholinergic activation of inhibitory interneurons, manifest clinically as decreased gating of response to sensory stimulation.
Similar articles
-
Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains.Neuropsychopharmacology. 1996 Aug;15(2):152-62. doi: 10.1016/0893-133X(95)00178-G. Neuropsychopharmacology. 1996. PMID: 8840351
-
Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.J Pharmacol Exp Ther. 1994 Jul;270(1):159-66. J Pharmacol Exp Ther. 1994. PMID: 8035312
-
Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.Synapse. 2004 Dec 1;54(3):147-55. doi: 10.1002/syn.20076. Synapse. 2004. PMID: 15452863
-
Schizophrenia and nicotinic receptors.Harv Rev Psychiatry. 1994 Nov-Dec;2(4):179-92. doi: 10.3109/10673229409017136. Harv Rev Psychiatry. 1994. PMID: 9384901 Review.
-
The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia.J Chem Neuroanat. 2000 Dec;20(3-4):299-306. doi: 10.1016/s0891-0618(00)00109-5. J Chem Neuroanat. 2000. PMID: 11207427 Review.
Cited by
-
Genetic knockout of the α7 nicotinic acetylcholine receptor gene alters hippocampal long-term potentiation in a background strain-dependent manner.Neurosci Lett. 2016 Aug 3;627:1-6. doi: 10.1016/j.neulet.2016.05.043. Epub 2016 May 24. Neurosci Lett. 2016. PMID: 27233215 Free PMC article.
-
Beauty of the beast: anticholinergic tropane alkaloids in therapeutics.Nat Prod Bioprospect. 2022 Sep 16;12(1):33. doi: 10.1007/s13659-022-00357-w. Nat Prod Bioprospect. 2022. PMID: 36109439 Free PMC article. Review.
-
Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy.Schizophr Res. 2013 Aug;148(1-3):138-44. doi: 10.1016/j.schres.2013.05.023. Epub 2013 Jun 13. Schizophr Res. 2013. PMID: 23768813 Free PMC article. Clinical Trial.
-
Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders.Biochem Pharmacol. 2015 Oct 15;97(4):388-398. doi: 10.1016/j.bcp.2015.07.027. Epub 2015 Jul 29. Biochem Pharmacol. 2015. PMID: 26231940 Free PMC article. Review.
-
Mouse models for studying genetic influences on factors determining smoking cessation success in humans.Ann N Y Acad Sci. 2012 Feb;1248:39-70. doi: 10.1111/j.1749-6632.2011.06415.x. Ann N Y Acad Sci. 2012. PMID: 22304675 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous